Letter Sequence Acceptance Review |
|---|
|
|
MONTHYEARML21035A0742021-01-29029 January 2021
Framatome, Inc. Request for Review and Approval of ANP-10353P, Revision 0, Increased Enrichment for PWRs
Project stage: Request
ML21061A2132021-03-0202 March 2021
Acceptance for Framatome Topical Report ANP-10353P - Increased Enrichment for PWRs
Project stage: Acceptance Review
ML21217A1012021-08-10010 August 2021
September 13, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10353, Revision 0, Increased Enrichment for PWRs
Project stage: Other
ML21258A3402021-09-21021 September 2021
Letter-Request for Additional Information Regarding Framatome Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs (Pressurized Water Reactors)
Project stage: RAI
ML21305A0322021-11-0303 November 2021
Report for September 13, 2021, Regulatory Audit Regarding Framatome Inc. Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs
Project stage: Other
PMNS20220371, Closed Meeting Between the U.S. Nuclear Regulatory Commission (NRC) and Framatome Inc. to Discuss Topical Report ANP-10353P, Revision 0 - Increased Enrichment for Pressurized Water Reactors (Pwrs)2022-04-0808 April 2022
Closed Meeting Between the U.S. Nuclear Regulatory Commission (NRC) and Framatome Inc. to Discuss Topical Report ANP-10353P, Revision 0 - Increased Enrichment for Pressurized Water Reactors (Pwrs)
Project stage: Request
ML22129A0032022-05-31031 May 2022
Letter - August 17, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs
Project stage: Other
ML22137A2712022-06-0101 June 2022
June 13-17, 2022, Audit Plan for Framatome Inc. TR, ANP-10311P-A, Rev. 1, Supplement 1P, Rev. 0, Cobra-FLX: ORFEO-HMP Critical Heat Flux Correlation and EMF-2310, Rev. 1, Supplement 2P, Rev. 0 (Epids L-2021-TOP-0004 & L-2022-TOP-0008)
Project stage: Other
ML22158A1472022-06-14014 June 2022
NRCs Revised Schedule for the Review of Framatomes Topical Reports, ANP-10353P, Rev. 0, Increased Enrichment for Pwrs and ANP-10340P, Rev. 0, Suppl. 1, Rev. 0, Incorporation of Chromia-Doped Fuel Properties in Framatome PWR Methods
Project stage: Approval
ML22252A2522022-09-15015 September 2022
Report Regarding August 17, 2022, Regulatory Audit for Framatome Inc. Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs - Letter -
Project stage: Other
ML22353A6042022-12-22022 December 2022
Audit Report Regarding Framatome TR, ANP-10311P-A, Rev. 1, Supplement 1P, Rev. 0, COBRA-FLX: ORFEO-HMP CHF Correlation & EMF-2310, Rev. 1, Supplement 2P, Rev. 0, SRP Chpt. 15 Non-LOCA Methodology for PWR (EPIDs L-2021-TOP-0004 & L-2022-TOP-
Project stage: Other
ML23023A2662023-01-26026 January 2023
Withholding Determination Regarding Request for Comment on Draft Safety Evaluation for ANP-10353P, Revision 0, Increased Enrichment for PWRs (EPID L-2021-TOP-0004) - Transmittal
Project stage: Draft Approval
ML23023A2732023-01-26026 January 2023
Withholding Determination Regarding Response to Request for Comment on Draft Safety Evaluation for Framatome Topical Report, ANP-10353P, Revision 0, Increased Enrichment for PWRs (EPID L-2021-TOP-0004) - Form 897
Project stage: Draft Approval
ML23053A0532023-03-22022 March 2023
Final Safety Evaluation for Framatome Topical Report ANP-10353P, Revision 0, Increased Enrichment for PWRs (Letter)
Project stage: Approval
ML23165A1902023-06-16016 June 2023
Withholding Determination for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs (Form 897)
Project stage: Other
ML23165A1882023-06-16016 June 2023
Withholding Determination for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs (EPID L-2021-TOP-0004) (Transmittal)
Project stage: Other
ML23167A0022023-06-28028 June 2023
Verification for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs
Project stage: Other
ML23167A0032023-06-28028 June 2023
Verification for Publication of Approved Framatome Topical Report, ANP-10353P-A, Revision 0, Increased Enrichment for PWRs EPID L-2021-TOP-0004
Project stage: Other
2022-05-31
[Table View] |
Text
1 Otto, Ngola From:
Otto, Ngola Sent:
Tuesday, March 02, 2021 12:39 PM To:
PETERS Gary (Framatome)
Cc:
Morey, Dennis; Lukes, Robert; Wise, Brandon; Heller, Kevin; Clifford, Paul; HOLM Jerald (Framatome);
BYRAM Morris (Framatome)
Subject:
Acceptance for Framatome Topical Report, ANP-10353P, Rev. 0, "Increased Enrichment for PWRs" EPID L-2021-TOP-0004; Docket No. 99902041
Dear Mr. Peters:
By letter dated January 29, 2021 (Agencywide Documents Access and Management System (ADAMS) Package Accession No. ML21035A073), Framatome, Inc. (Framatome) submitted for review and approval, Topical Report (TR) ANP-10353P, "Increased Enrichment for PWRs". In the letter, Framatome stated that the TR ANP-10353P provides a justification for increasing the enrichment for Pressurized Water Reactors (PWRs) to above 5 Weight-percent of Uranium (U)-235. Framatome is also requesting approval of the TR by July 2022. The NRC staff have found that the material presented in the TR ANP-10353P is sufficient to begin our review. The NRC staff plan to issue requests for additional information (RAIs) by September 14, 2021, and draft safety evaluation (SE) by May 6, 2022.
This schedule information takes into consideration the NRCs current review priorities and available technical resources and may be subject to change. If modifications to these dates are deemed necessary, we will provide appropriate updates to this information. The NRC staff estimates that the review will require approximately 1200 staff-hours including project management. The review schedule milestones and estimated review costs were discussed and agreed upon between Jerald Holm and the NRC staff on March 2, 2021. This email will be placed in ADAMS and made Official Agency Records and declared public.
Section 170.21 of Title 10 of the Code of Federal Regulations requires that topical reports are subject to fees based on the full cost of the review. You did not request a fee waiver; therefore, NRC staff-hours will be billed accordingly.
If you have any questions or require any additional information, please feel free to contact me at (301) 415 6695 or by email.
Sincerely, Ngola Otto Project Manager, Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation US Nuclear Regulatory Commission e-mail: Ngola.Otto@nrc.gov phone: (301) 415-6695